In
the previous article we read about the signs and symptoms of Non-
Hodgkins Lymphoma. In this article we talk about the different
kind of treatments available for a person suffering from this
lymphoma. The doctor develops a treatment plan to fit each patient's
needs. Treatment for non-Hodgkin's lymphoma depends on the stage
of the disease, the type of cells involved, whether they are indolent
or aggressive, and the age and general health of the patient.
In some cases, bone marrow transplantation, biological treatments
or surgery may be options. For indolent lymphomas, the doctor
may decide to wait until the disease causes symptoms before starting
treatment. Often, this approach is called "watchful waiting."

Methods Of Treatment
Chemotherapy
Chemotherapy and radiation therapy are the most common treatments
for non-Hodgkin's lymphoma, although bone marrow transplantation,
biological therapies, or surgery are sometimes used. Chemotherapy
for non-Hodgkin's lymphoma usually consists of a combination of
several drugs. Patients may receive chemotherapy alone or in combination
with radiation therapy.
Radiation Therapy
Radiation therapy is the use of high-energy rays to kill cancer
cells. Treatment with radiation may be given alone or with chemotherapy.
Radiation therapy is local treatment; it affects cancer cells
only in the treated area. Radiation therapy for non-Hodgkin's
lymphoma comes from a machine that aims the high-energy rays at
a specific area of the body. There is no radioactivity in the
body when the treatment is over.
Bone Marrow Transplantation (BMT)
Bone marrow transplantation (BMT) may also be a treatment option,
especially for patients whose non-Hodgkin's lymphoma has recurred
(come back). BMT provides the patient with healthy stem cells
(very immature cells that produce blood cells) to replace cells
damaged or destroyed by treatment with very high doses of chemotherapy
and/or radiation therapy. The healthy bone marrow may come from
a donor, or it may be marrow that was removed from the patient,
treated to destroy cancer cells, stored, and then given back to
the person following the high-dose treatment. Until the transplanted
bone marrow begins to produce enough white blood cells, patients
have to be carefully protected from infection. They usually stay
in the hospital for several weeks.
Biological Therapy
Biological therapy (also called immunotherapy) is a form of treatment
that uses the body's immune system, either directly or indirectly,
to fight cancer or to lessen the side effects that can be caused
by some cancer treatments. It uses materials made by the body
or made in a laboratory to boost, direct, or restore the body's
natural defenses against disease.
Surgery
Surgery may be performed to remove a tumor. Tissue around the
tumor and nearby lymph nodes may also be removed during the operation.
Risk Factors Associated With Non-Hodgkin's
Lymphoma
The incidence of non-Hodgkin's lymphoma has increased dramatically
over the last couple of decades. This disease has gone from being
relatively rare to being the fifth most common cancer in the U.S.
At this time, little is known about the reasons for this increase
or about exactly what causes non-Hodgkin's lymphoma.
Doctors can seldom explain why one person gets non-Hodgkin's lymphoma
and another does not. It is clear, however, that cancer is not
caused by an injury, and is not contagious; no one can "catch"
non-Hodgkin's lymphoma from another person.
By studying patterns of cancer in the population, researchers
have found certain risk factors that are more common in people
who get non-Hodgkin's lymphoma than in those who do not. However,
most people with these risk factors do not get non-Hodgkin's lymphoma,
and many who do get this disease have none of the known risk factors.
| Following
Are Some Of The Risk Factors Associated With This Disease: |
| Age/Sex--The
likelihood of getting non-Hodgkin's lymphoma increases with
age and is more common in men than in women. |
| Weakened
Immune System--Non-Hodgkin's lymphoma is more common among
people with inherited immune deficiencies, autoimmune diseases,
or HIV/AIDS, and among people taking immunosuppressant drugs
following organ transplants. |
| Viruses--Human
T-lymphotropic virus type I (HTLV-1) and Epstein-Barr virus
are two infectious agents that increase the chance of developing
non-Hodgkin's lymphoma. |
| Environment--People
who work extensively with or are otherwise exposed to certain
chemicals, such as pesticides, solvents, or fertilizers, have
a greater chance of developing non-Hodgkin's lymphoma. |
People who are concerned about non-Hodgkin's lymphoma should talk
with their doctor about the disease, the symptoms to watch for,
and an appropriate schedule for checkups. The doctor's advice
will be based on the person's age, medical history, and other
factors.